Top Markets
Coin of the day
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Classement en actions #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Prix de l'action
$0.52468396
Capitalisation boursière
$37.85M
Changement (1 jour)
1.23%
Changement (1 an)
-4.53%
Pays
TW
Échange Enimmune corporation (6564)

Catégorie

Historique du prix de l'action pour Enimmune corporation (6564)
Prix de clôture le plus élevé : $0.53 le 2026-08-01

Prix de clôture le plus bas : $0.89 le 2018-09-01
Historique du prix de l'action de Enimmune corporation de 2018 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -7.73%
2025 -21.37%
2024 -30.67%
2023 -42.89%
2022 47.58%
2021 -3.50%
2020 86.97%
2019 -4.98%
2018 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$542.77 37.63%
US
$1.03K 55.84%
NL
$120.74 -14.98%
AU
$145.16 439.84%
US
$756.15 6.24%
CH